US Stock MarketDetailed Quotes

RAPP Rapport Therapeutics

Watchlist
  • 10.050
  • -0.170-1.66%
Close Mar 25 16:00 ET
  • 9.700
  • -0.350-3.48%
Pre 05:29 ET
366.79MMarket Cap-4.69P/E (TTM)

Rapport Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-138.50%-64.83M
-39.48%-14.45M
-202.64%-16.42M
-147.80%-16.35M
-266.90%-17.62M
-27.18M
-10.36M
-5.42M
-6.6M
-4.8M
Net income from continuing operations
-125.11%-78.31M
-47.79%-19.98M
-101.37%-17.54M
-182.65%-18.12M
-268.78%-22.67M
---34.79M
---13.52M
---8.71M
---6.41M
---6.15M
Operating gains losses
557.47%7.39M
--0
--0
--0
617.48%7.39M
--1.12M
--94K
--0
--0
--1.03M
Depreciation and amortization
649.11%839K
390.57%260K
852.17%219K
890.48%208K
913.33%152K
--112K
--53K
--23K
--21K
--15K
Other non cash items
140.45%642K
11.49%165K
--162K
--159K
--156K
--267K
--148K
----
----
----
Change In working capital
-191.10%-2.42M
-31.02%1.34M
-120.88%-477K
89.34%-123K
-648.10%-3.16M
--2.65M
--1.94M
--2.28M
---1.15M
---422K
-Change in prepaid assets
42.06%-1.85M
99.36%-12K
-232.28%-672K
173.95%900K
-241.58%-2.07M
---3.2M
---1.89M
--508K
---1.22M
---606K
-Change in payables and accrued expense
-99.60%25K
-63.53%1.5M
-79.06%364K
-2,305.00%-882K
-367.70%-953K
--6.24M
--4.1M
--1.74M
--40K
--356K
-Change in other current assets
134.58%83K
127.83%32K
--0
4.35%24K
115.70%27K
---240K
---115K
--24K
--23K
---172K
-Change in other current liabilities
-365.28%-670K
-10.76%-175K
-1,307.14%-169K
---165K
---161K
---144K
---158K
--14K
--0
--0
Cash from discontinued investing activities
Operating cash flow
-138.50%-64.83M
-39.48%-14.45M
-202.64%-16.42M
-147.80%-16.35M
-266.90%-17.62M
---27.18M
---10.36M
---5.42M
---6.6M
---4.8M
Investing cash flow
Cash flow from continuing investing activities
-115.75%-170.14M
140.59%31.93M
-101,901.92%-53.04M
-124,439.53%-107.1M
-68,631.15%-41.93M
-78.86M
-78.66M
-52K
-86K
-61K
Net PPE purchase and sale
-47.00%-2.41M
84.27%-226K
-169.23%-140K
-1,024.42%-967K
-1,657.38%-1.07M
---1.64M
---1.44M
---52K
---86K
---61K
Net investment purchase and sale
-117.21%-167.74M
141.64%32.16M
---52.9M
---106.14M
---40.85M
---77.22M
---77.22M
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
-115.75%-170.14M
140.59%31.93M
-101,901.92%-53.04M
-124,439.53%-107.1M
-68,631.15%-41.93M
---78.86M
---78.66M
---52K
---86K
---61K
Financing cash flow
Cash flow from continuing financing activities
52.70%221.63M
105.00%7K
-101.63%-1.39M
177,158.89%159.35M
6.09%63.66M
145.14M
-140K
85.36M
-90K
60.01M
Net common stock issuance
315,310.00%157.71M
--0
-34,750.00%-1.39M
530,230.00%159.1M
--0
--50K
--0
---4K
--30K
--24K
Net preferred stock issuance
-55.99%63.91M
--0
--0
63.75%-29K
6.57%63.94M
--145.22M
---6K
--85.31M
---80K
--60M
Proceeds from stock option exercised by employees
--7K
----
----
----
----
--0
----
----
----
----
Net other financing activities
----
----
----
----
-1,472.22%-283K
---134K
----
----
---40K
---18K
Cash from discontinued financing activities
Financing cash flow
52.70%221.63M
105.00%7K
-101.63%-1.39M
177,158.89%159.35M
6.09%63.66M
--145.14M
---140K
--85.36M
---90K
--60.01M
Net cash flow
Beginning cash position
125.47%70.25M
-75.27%39.42M
38.65%110.27M
-13.82%74.37M
125.47%70.25M
--31.16M
--159.41M
--79.53M
--86.3M
--31.16M
Current changes in cash
-134.13%-13.34M
119.62%17.49M
-188.69%-70.85M
629.85%35.9M
-92.53%4.12M
--39.1M
---89.16M
--79.88M
---6.78M
--55.14M
End cash Position
-18.99%56.91M
-18.99%56.91M
-75.27%39.42M
38.65%110.27M
-13.82%74.37M
--70.25M
--70.25M
--159.41M
--79.53M
--86.3M
Free cash flow
-133.31%-67.23M
-24.40%-14.67M
-202.32%-16.56M
-159.07%-17.32M
-284.35%-18.69M
---28.82M
---11.79M
---5.48M
---6.69M
---4.86M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -138.50%-64.83M-39.48%-14.45M-202.64%-16.42M-147.80%-16.35M-266.90%-17.62M-27.18M-10.36M-5.42M-6.6M-4.8M
Net income from continuing operations -125.11%-78.31M-47.79%-19.98M-101.37%-17.54M-182.65%-18.12M-268.78%-22.67M---34.79M---13.52M---8.71M---6.41M---6.15M
Operating gains losses 557.47%7.39M--0--0--0617.48%7.39M--1.12M--94K--0--0--1.03M
Depreciation and amortization 649.11%839K390.57%260K852.17%219K890.48%208K913.33%152K--112K--53K--23K--21K--15K
Other non cash items 140.45%642K11.49%165K--162K--159K--156K--267K--148K------------
Change In working capital -191.10%-2.42M-31.02%1.34M-120.88%-477K89.34%-123K-648.10%-3.16M--2.65M--1.94M--2.28M---1.15M---422K
-Change in prepaid assets 42.06%-1.85M99.36%-12K-232.28%-672K173.95%900K-241.58%-2.07M---3.2M---1.89M--508K---1.22M---606K
-Change in payables and accrued expense -99.60%25K-63.53%1.5M-79.06%364K-2,305.00%-882K-367.70%-953K--6.24M--4.1M--1.74M--40K--356K
-Change in other current assets 134.58%83K127.83%32K--04.35%24K115.70%27K---240K---115K--24K--23K---172K
-Change in other current liabilities -365.28%-670K-10.76%-175K-1,307.14%-169K---165K---161K---144K---158K--14K--0--0
Cash from discontinued investing activities
Operating cash flow -138.50%-64.83M-39.48%-14.45M-202.64%-16.42M-147.80%-16.35M-266.90%-17.62M---27.18M---10.36M---5.42M---6.6M---4.8M
Investing cash flow
Cash flow from continuing investing activities -115.75%-170.14M140.59%31.93M-101,901.92%-53.04M-124,439.53%-107.1M-68,631.15%-41.93M-78.86M-78.66M-52K-86K-61K
Net PPE purchase and sale -47.00%-2.41M84.27%-226K-169.23%-140K-1,024.42%-967K-1,657.38%-1.07M---1.64M---1.44M---52K---86K---61K
Net investment purchase and sale -117.21%-167.74M141.64%32.16M---52.9M---106.14M---40.85M---77.22M---77.22M--0--0--0
Cash from discontinued investing activities
Investing cash flow -115.75%-170.14M140.59%31.93M-101,901.92%-53.04M-124,439.53%-107.1M-68,631.15%-41.93M---78.86M---78.66M---52K---86K---61K
Financing cash flow
Cash flow from continuing financing activities 52.70%221.63M105.00%7K-101.63%-1.39M177,158.89%159.35M6.09%63.66M145.14M-140K85.36M-90K60.01M
Net common stock issuance 315,310.00%157.71M--0-34,750.00%-1.39M530,230.00%159.1M--0--50K--0---4K--30K--24K
Net preferred stock issuance -55.99%63.91M--0--063.75%-29K6.57%63.94M--145.22M---6K--85.31M---80K--60M
Proceeds from stock option exercised by employees --7K------------------0----------------
Net other financing activities -----------------1,472.22%-283K---134K-----------40K---18K
Cash from discontinued financing activities
Financing cash flow 52.70%221.63M105.00%7K-101.63%-1.39M177,158.89%159.35M6.09%63.66M--145.14M---140K--85.36M---90K--60.01M
Net cash flow
Beginning cash position 125.47%70.25M-75.27%39.42M38.65%110.27M-13.82%74.37M125.47%70.25M--31.16M--159.41M--79.53M--86.3M--31.16M
Current changes in cash -134.13%-13.34M119.62%17.49M-188.69%-70.85M629.85%35.9M-92.53%4.12M--39.1M---89.16M--79.88M---6.78M--55.14M
End cash Position -18.99%56.91M-18.99%56.91M-75.27%39.42M38.65%110.27M-13.82%74.37M--70.25M--70.25M--159.41M--79.53M--86.3M
Free cash flow -133.31%-67.23M-24.40%-14.67M-202.32%-16.56M-159.07%-17.32M-284.35%-18.69M---28.82M---11.79M---5.48M---6.69M---4.86M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Market Insights

Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Tesla
TSLA
288.140
Adobe
ADBE
403.640
Ecopetrol
EC
10.310
4
Petroleo Brasileiro SA Petrobras
PBR
14.270
5
Strategy
MSTR
341.810
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More
FOMC Press Conference, March 19, 2025